The GIFT Act of 2025 amends Title XVIII of the Social Security Act to prohibit hospitals from considering vaccination status when selecting organ transplant recipients. The bill adds a new subparagraph (Z) to Section 1866(a)(1), banning hospitals, critical access hospitals, and rural emergency hospitals from weighing vaccination status in organ allocation decisions.
Its aim is to ensure that access to life-saving transplants is determined by medical need and compatibility rather than vaccination history. While the text is narrow, its significance lies in creating a uniform standard across Medicare-participating facilities to prevent vaccination status from guiding scarce organ allocation decisions.
At a Glance
What It Does
The bill adds a new subparagraph to 1866(a)(1) prohibiting hospitals from considering an individual’s vaccination status when determining organ transplant recipients.
Who It Affects
Hospitals, including critical access and rural emergency facilities, and the Medicare population awaiting organ transplants.
Why It Matters
It establishes a uniform non-discrimination rule in transplant allocation, potentially expanding equitable access for Medicare beneficiaries regardless of vaccination status.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The proposed GIFT Act would change how organ transplants are allocated for patients who rely on Medicare. By amending Section 1866(a)(1) in Title XVIII, the bill creates a hard rule: vaccination status cannot influence which patient gets an organ transplant.
The prohibition covers hospitals, critical access hospitals, and rural emergency hospitals that perform transplants, ensuring that decisions are based on medical need and compatibility rather than whether a patient is vaccinated. The bill does not spell out penalties or a specific enforcement mechanism in the text provided, nor does it specify an effective date.
Instead, it codifies a standard that would guide hospital and transplant program policies once implemented by the CMS framework.
The Five Things You Need to Know
Section 1866(a)(1) is amended to add Subparagraph Z prohibiting vaccination status as a transplant criterion.
The prohibition covers hospitals, critical access hospitals, and rural emergency hospitals.
The Act targets Medicare’s Title XVIII framework by amending the Social Security Act.
There are no explicit penalties or effective date specified in the text.
The measure seeks uniform, non-discriminatory organ allocation across Medicare-participating facilities.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Section 1 designates the act as the GIFT Act of 2025, providing the formal citation for the statute. This establishes the legislative identity of the measure and signals its scope in the Medicare/organ transplant context.
Prohibition on considering vaccination status in organ recipient selection
Section 2 amends Section 1866(a)(1) by adding a new subparagraph (Z) that prohibits hospitals (including critical access and rural emergency hospitals) from taking vaccination status into account when determining which individual should receive an organ transplant. This is the operative provision that converts the policy into a codified standard applicable to transplant decisions within the Medicare framework.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare beneficiaries seeking organ transplants who would otherwise be affected by vaccination-based allocation criteria.
- Transplant programs at Medicare-participating hospitals seeking clear, non-discriminatory allocation rules.
- Organ Procurement Organizations (OPOs) coordinating nationwide organ allocation to ensure consistent standards across facilities.
- CMS/Medicare program offices responsible for implementing and overseeing transplant policies.
Who Bears the Cost
- Hospitals and transplant teams must adjust policies, screening processes, and documentation to ensure vaccination status is not used in decisions.
- OPOs will need to modify allocation workflows and data reporting to align with the new rule.
- Medicare administrative resources may be required to monitor and enforce compliance with the prohibition.
Key Issues
The Core Tension
The central tension is balancing non-discriminatory access to life-saving organs with public health and clinical risk considerations. Removing vaccination status as a criterion safeguards equity but raises questions about how other risk factors are weighed and how compliance will be verified across many hospitals and jurisdictions.
The bill foregrounds a non-discrimination principle in a high-stakes medical domain, but it leaves several technical questions open. How vaccination status will be verified or challenged in the allocation process is not specified, nor is there an enforcement mechanism or a defined effective date within the bill text.
Practically, facilities will need to reconcile the prohibition with existing clinical criteria for organ matching (e.g., medical urgency, compatibility) while maintaining transparent decision-making records. The shift could generate transitional costs as hospitals and OPOs adjust policies, data systems, and training to ensure uniform application across diverse settings.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.